Industry leaders discuss changing landscape under Sunshine ActSeptember 27, 2013
As part of the Presidents’ Council at Optometry’s Meeting®, representatives from industry engaged in discussion about the physician Sunshine Act and its implications for corporate support.
The Sunshine Act is part of the Affordable Care Act and ensures more transparency for the public.
Its provisions require manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the federal Children’s Health Insurance Program (CHIP) to report payments or other transfers of value they make to physicians and teaching hospitals to the Centers for Medicare & Medicaid Services (CMS).
Representatives noted the act does not prohibit payments or gifts, it simply requires the disclosure of them.
Data collection began Aug. 1 as part of the CMS Sunshine rule announced in February. The CMS will release the data on a public website by Sept. 30, 2014.
To access AOA resources regarding the Sunshine Act, visit www.aoa.org/advocacy/ health-care-reform/the-sunshine-act.